Clinical Implications box: Baricitinib seems safe and effective in reducing the articular flares, controlling the systemic inflammation and lung disease progression of COPA patients. The drug dosage should be adjusted according to patient’s age and weight in order to prevent disease flares.

Baricitinib treatment in children with COPA syndrome

Corona, Federica;Pastore, Serena;Tommasini, Alberto;
2024-01-01

Abstract

Clinical Implications box: Baricitinib seems safe and effective in reducing the articular flares, controlling the systemic inflammation and lung disease progression of COPA patients. The drug dosage should be adjusted according to patient’s age and weight in order to prevent disease flares.
File in questo prodotto:
File Dimensione Formato  
Baricitinib treatment in children.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 1.23 MB
Formato Adobe PDF
1.23 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3081601
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact